IGF1R and breast cancer: (ii) The present findings reveal the critical role of SMYD3-mediated activation of the IGF-1R-AKT axis in BC, however, based on published reports, it is likely that SMYD3 contributes to BC pathogenesis via multiple mechanisms, which calls for further studies.